BRAGGSS

Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate

The BRAGGSS Study collects data from patients receiving biologic therapy to evaluate the role of genetic variation, psychological status, clinical variables, serological measures and environmental factors in determining response to treatment.

This website is for researchers only. If you are a participant and would like some more information please contact:

Sarah Ashton, Study Coordinator ( sarah.ashton-2@manchester.ac.uk)
Tel: 0778 569 2979


Clinician Login
Login >